Several DEA agents inspected Dr. Mithoefer’s facility today as part of DEA’s review of his application for a Schedule I license to handle the 3.5 grams of MDMA needed for the entire study. The inspectors focused on issues of diversion control and checked out the safe, the alarm system and the forms and procedures that will be used to track all of the MDMA and placebo capsules. The DEA agents were interested in helping Dr. Mithoefer understand and follow their rules and were quite reasonable. Dr. Mithoefer was told he will probably receive his license in several weeks to several months.